HOLMESv2: A CRISPR-Cas12b-Assisted Platform for Nucleic Acid Detection and DNA Methylation Quantitation.
Linxian LiShiyuan LiNa WuJiacheng WuGang WangGuoping ZhaoJing-Man WangPublished in: ACS synthetic biology (2019)
The next-generation CRISPR-based molecular diagnostics has the merits of rapidness, accuracy, and portability. We discovered the Cas12a trans-cleavage activity against collateral single-stranded DNA (ssDNA) and employed the activity to develop a rapid nucleic acid detection system, namely HOLMES (one-hour low-cost multipurpose highly efficient system). Here, with the employment of thermophilic CRISPR-Cas12b, we create HOLMESv2 for four different applications: (1) specifically discriminating single nucleotide polymorphism (SNP); (2) simply detecting virus RNA, human cell mRNA and circular RNA; (3) conveniently quantitating target nucleic acids with a one-step system combined with LAMP amplification in a constant temperature, thus avoiding cross-contamination; (4) accurately quantitating target DNA methylation degree with the combination of Cas12b detection and bisulfite treatment. These results highlight the potential of HOLMESv2 as a promising platform for both molecular diagnostics and epigenetics applications.
Keyphrases
- nucleic acid
- crispr cas
- genome editing
- loop mediated isothermal amplification
- dna methylation
- highly efficient
- genome wide
- low cost
- sensitive detection
- gene expression
- label free
- real time pcr
- endothelial cells
- blood pressure
- high throughput
- ms ms
- mass spectrometry
- single cell
- cell therapy
- transcription factor
- bone marrow
- single molecule
- liquid chromatography tandem mass spectrometry
- human health
- mental illness
- high resolution
- mesenchymal stem cells
- climate change
- binding protein
- circulating tumor